Phase III Data And GMP Nod Bring Prestige’s Trastuzumab Closer To Launch
Latest Developments Bode Well For Tuznue Biosimilar Rival To Herceptin
• By David Wallace
Two positive developments will allow Prestige to move forward • Source: Stocksolutions / Alamy Stock Photo 
